Open AccessClinical Importance of FNDC-5 and Selectin-E mRNA Expression Among Type 2 Diabetics with and without Obesity
Author(s) -
Amit Verma,
Alanoud Aladel,
Sadaf Dabeer,
Irfan Ahmad,
Mohammad Idreesh Khan,
Malak Almutairi,
Alhanouf I. Al-Harbi,
Mirza Masroor Ali Beg
Publication year - 2022
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s352483
Subject(s) - medicine , type 2 diabetes mellitus , obesity , endocrinology , vitamin d and neurology , glycated hemoglobin , diabetes mellitus , type 2 diabetes , vitamin d deficiency , blood pressure
Type 2 diabetes mellitus (T2DM) is growing illnesses associated with metabolic dysregulation such as obesity affecting a large population become leading causes of death worldwide. Fibronectin type III domain-containing protein 5 (FNDC-5) and selectin-E were suggested to have effects on metabolism and diabetes, therefore present study aimed to evaluate the clinical importance of FNDC-5 and selectin-E among the T2DM patients with and without obesity.